Lv2
110 积分 2025-05-21 加入
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
22天前
已完结
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF
1个月前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial
6个月前
已完结
Chronic kidney disease
6个月前
已关闭
The expanding landscape of genetic causes of obesity
7个月前
已完结
FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression
11个月前
已完结
Approaching a therapeutic inflection point for FLT3-mutated AML
1年前
已完结
皖公网安备34019202002308
